Business Wire
21 Oct 2026, 05:00 UTC · 1h ago
Impact · against what's priced in
Innate Pharma's participation in upcoming healthcare conferences is a routine visibility event with negligible impact on valuation.
Scored by the NIS engine · methodology.
Which stocks this story touches
More positive than 52% of ticker scores this week
Innate Pharma is presenting at healthcare conferences, which generally increases investor visibility.
Continue reading
5 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
8h ago
